CONFERENCE COVERAGE SERIES
Keystone Symposium: Alzheimer's Disease 2006
Beaver Run Resort, Breckenridge, Colorado
01 – 05 April 2006
Keystone Symposia Meeting, Part 1—Alzheimer’s Disease: Genes, Cellular Pathways and Therapies
Minji Kim, Alice Lu, and Rudy Tanzi report on the recent Keystone Symposium on Alzheimer disease, which focused on the molecular underpinnings of Alzheimer disease (AD) and frontal temporal dementia (FTD), covering...
Keystone Symposia Meeting, Part 2—Genetics and Epidemiology of AD
Part 2 of our report by Minji Kim, Alice Lu, and Rudy Tanzi. Steve Younkin, Mayo Clinic at Jacksonville, Florida, presented the recent progress in identification of...
Keystone Symposia Meeting, Part 3—Amyloid Precursor Protein Function
This is part 3 of our report by Minji Kim, Alice Lu, and Rudy Tanzi. Sam Gandy, Thomas Jefferson University, Philadelphia, reviewed the trafficking pathways of APP from the endoplasmic reticulum (ER) to...
Keystone Symposia Meeting, Part 4—Presenilin and γ-secretase
In part 4 of our report, Minji Kim, Alice Lu, and Rudy Tanzi summarize presentations by Dennis Selkoe, Christian Haass, Bart De Strooper, Jie Shen, Homira Behbahani, and Taisuke Tomita...
Keystone Symposia Meeting, Part 5—β-secretase
In part 5 of our report, Minji Kim, Alice Lu, and Rudy Tanzi summarize some new data on β-secretase, including...
Keystone Symposia Meeting, Part 6—Tau and FTD
In part 6 of our Keystone Symposia Meeting summary, Minji Kim, Alice Lu, and Rudy Tanzi relay new developments in tau biology and frontotemporal dementia...
Keystone Symposia Meeting, Part 7—Aβ Clearance
New insights into the role of ApoE, the blood-brain barrier, and degrading enzymes in clearance of Aβ...
Keystone Symposia Meeting, Part 8—Animal Models and Therapeutics; Therapeutics and Imaging
The last part of our Keystone Symposia meeting covers the last two sessions on therapeutics...